In order to investigate the potential mechanism of BDS-hEA inhibiting HCC tumor growth, immunofluorescence staining was employed to analyze the expression changes of tumor proliferation (ki67), migration (MMP-9), and angiogenesis (CD31 and VEGF). The gene discussed is PECAM1; the disease is hepatocellular carcinoma.